2022
DOI: 10.1155/2022/1149231
|View full text |Cite
|
Sign up to set email alerts
|

Atractylenolide III Attenuates Apoptosis in H9c2 Cells by Inhibiting Endoplasmic Reticulum Stress through the GRP78/PERK/CHOP Signaling Pathway

Abstract: The objective of this study was to determine the effect of atractylenolide III (ATL-III) on endoplasmic reticulum stress (ERS) injury, H9c2 cardiomyocyte apoptosis induced by tunicamycin (TM), and the GRP78/PERK/CHOP signaling pathway. Molecular docking was applied to predict the binding affinity of ATL-III to the key proteins GRP78, PERK, IREα, and ATF6 in ERS. Then, in vitro experiments were used to verify the molecular docking results. ERS injury model of H9c2 cells was established by TM. Cell viability was… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(2 citation statements)
references
References 42 publications
0
1
0
Order By: Relevance
“…To delve deeper into the potential mechanism of ER stress-induced apoptosis in HK-2 cells, alterations in Caspase 12, a prominent marker of ER stress, were examined through an immunofluorescence assay [ 37 ]. The findings notably unveiled that exposure to nano-COM elicited a substantial rise in Caspase 12 expression.…”
Section: Resultsmentioning
confidence: 99%
“…To delve deeper into the potential mechanism of ER stress-induced apoptosis in HK-2 cells, alterations in Caspase 12, a prominent marker of ER stress, were examined through an immunofluorescence assay [ 37 ]. The findings notably unveiled that exposure to nano-COM elicited a substantial rise in Caspase 12 expression.…”
Section: Resultsmentioning
confidence: 99%
“…ATL III was discovered to reduce apoptosis and ROS, MDA, and LDH levels in H 2 O 2 -induced endoplasmic reticulum stress-injured cardiomyocytes H9c2, increase SOD activity and protect cardiomyocytes by regulating the ROS/GRP78/Caspase-12 signaling pathway, which could be a potential drug for the treatment of chronic heart failure according to Zuo et al [ 84 ]. In addition, by inhibiting GRP 78/PERK/CHOP signaling pathway, ATL III can also inhibit the endoplasmic reticulum stress injury induced by chlamycin and the apoptosis of H9c2 cardiomyocytes, thus protecting myocardium [ 85 ]. In patients with advanced chronic renal disease, muscle atrophy owing to oxidative stress is a typical consequence.…”
Section: Pharmacological Effects Of Atractylenolidesmentioning
confidence: 99%